|
- 2019
Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacksDOI: 10.1186/s13223-019-0328-3 Keywords: C1-inhibitor deficiency, C1-INH protein, Crossover studies, Self-administration, Subcutaneous, Intravenous, C1-inhibitor replacement therapy, HAEGARDA, Cinryze Abstract: Features of COMPACT [14] and CHANGE [11, 17] studie
|